Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

The comparative effectiveness of heart disease prevention and treatment strategies.

Kottke TE, Faith DA, Jordan CO, Pronk NP, Thomas RJ, Capewell S.

Am J Prev Med. 2009 Jan;36(1):82-88. doi: 10.1016/j.amepre.2008.09.010. Review.

PMID:
19095166
3.

Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S.

N Engl J Med. 2007 Jun 7;356(23):2388-98.

4.

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Circulation. 2007 Feb 6;115(5):e69-171. Epub 2006 Dec 28. No abstract available. Erratum in: Circulation. 2007 Feb 6;115(5):e172. Circulation. 2010 Jul 6;122(1):e9. Kissela, Bret [corrected to Kissela, Brett].

5.
6.

Statins and mortality among elderly patients hospitalized with heart failure.

Foody JM, Shah R, Galusha D, Masoudi FA, Havranek EP, Krumholz HM.

Circulation. 2006 Feb 28;113(8):1086-92. Epub 2006 Feb 20.

7.

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators.

Lancet. 2005 Oct 8;366(9493):1267-78. Epub 2005 Sep 27. Erratum in: Lancet. 2005 Oct 15-21;366(9494):1358. Lancet. 2008 Jun 21;371(9630):2084.

PMID:
16214597
8.

Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation.

Hartwell D, Colquitt J, Loveman E, Clegg AJ, Brodin H, Waugh N, Royle P, Davidson P, Vale L, MacKenzie L.

Health Technol Assess. 2005 May;9(17):1-99, iii-iv. Review.

9.

Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999.

Critchley J, Liu J, Zhao D, Wei W, Capewell S.

Circulation. 2004 Sep 7;110(10):1236-44. Epub 2004 Aug 30.

10.

Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials.

Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone JA, Thompson DR, Oldridge N.

Am J Med. 2004 May 15;116(10):682-92. Review.

PMID:
15121495
11.
12.

Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.

Unal B, Critchley JA, Capewell S.

Circulation. 2004 Mar 9;109(9):1101-7. Epub 2004 Mar 1.

13.

Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH).

Piepoli MF, Davos C, Francis DP, Coats AJ; ExTraMATCH Collaborative.

BMJ. 2004 Jan 24;328(7433):189. Epub 2004 Jan 16.

14.
15.

Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial.

Ottervanger JP, Armstrong P, Barnathan ES, Boersma E, Cooper JS, Ohman EM, James S, Topol E, Wallentin L, Simoons ML; GUSTO IV-ACS Investigators.

Circulation. 2003 Jan 28;107(3):437-42.

16.

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Antithrombotic Trialists' Collaboration.

BMJ. 2002 Jan 12;324(7329):71-86. Erratum in: BMJ 2002 Jan 19;324(7330):141.

17.

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators.

N Engl J Med. 2001 Aug 16;345(7):494-502. Erratum in: N Engl J Med 2001 Nov 15;345(20):1506. N Engl J Med 2001 Dec 6;345(23):1716.

18.

Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure.

Shibata MC, Flather MD, Wang D.

Eur J Heart Fail. 2001 Jun;3(3):351-7. Review.

19.

Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993.

Capewell S, Beaglehole R, Seddon M, McMurray J.

Circulation. 2000 Sep 26;102(13):1511-6.

20.

Physical activity and mortality in older men with diagnosed coronary heart disease.

Wannamethee SG, Shaper AG, Walker M.

Circulation. 2000 Sep 19;102(12):1358-63.

Items per page

Supplemental Content

Write to the Help Desk